Current Issue Sep-Oct 2025; Volume 5, Issue 5
ISSUE HIGHLIGHTS
Risk Factors for Infusion Reactions Associated With Rituximab Therapy
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
552-556
DOI: 10.21873/cdp.10469
GLIM Criteria as Prognostic Factor in Patients Undergoing Adjuvant S‐1 Chemotherapy for Biliary Tract Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
557-565
DOI: 10.21873/cdp.10470
Young Women With Endometrial Cancer: A Portuguese Perspective
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
606-613
DOI: 10.21873/cdp.10475
Definitive Diagnosis of Angiomatoid Fibrous Histiocytoma Using Dual DNA/RNA Genomic Profiling
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
620-624
DOI: 10.21873/cdp.10477
Purchase access
Email Alerts
Table of contents Sep-Oct 2025; Volume 5, Issue 5
Review article
The Prognostic Role of Lymphatic Vessel Density in Papillary Thyroid Carcinoma: A Systematic Review and Meta‐analysis
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
542-551
DOI: 10.21873/cdp.10468
Research articles
Risk Factors for Infusion Reactions Associated With Rituximab Therapy
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
552-556
DOI: 10.21873/cdp.10469
GLIM Criteria as Prognostic Factor in Patients Undergoing Adjuvant S‐1 Chemotherapy for Biliary Tract Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
557-565
DOI: 10.21873/cdp.10470
Surgical Measures Improving Functional Limitations of the Masticatory System, Aesthetic Deficits, and Skeletal Malformations in Neurofibromatosis Type 1‐associated Hemifacial Diffuse Plexiform Neurofibroma Complicated by Rapidly Growing Midfacial Peripheral Nerve Sheath Tumor
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
566-582
DOI: 10.21873/cdp.10471
Treatment Response and Survival in Thyroid Transcription Factor‐1 Negative Non‐squamous Non‐small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
583-590
DOI: 10.21873/cdp.10472
Efficacy of Durvalumab‐Tremelimumab Treatment in Combination With Locoregional Therapy in Unresectable Hepatocellular Carcinoma: A Preliminary Study
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
591-596
DOI: 10.21873/cdp.10473
Prognostic Impact of Sarcopenia on Clinical Outcomes in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
597-605
DOI: 10.21873/cdp.10474
Young Women With Endometrial Cancer: A Portuguese Perspective
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
606-613
DOI: 10.21873/cdp.10475
Eradication of Extensive Lymph‐Node, Bone and Pleural Metastases of a Breast‐Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
614-619
DOI: 10.21873/cdp.10476
Definitive Diagnosis of Angiomatoid Fibrous Histiocytoma Using Dual DNA/RNA Genomic Profiling
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
620-624
DOI: 10.21873/cdp.10477
MRS Imaging as Complement to MRI in the Post‐treatment Follow‐up of Glial Brain Tumors
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
625-633
DOI: 10.21873/cdp.10478
Asymptomatic Troponin Elevation and Early Mortality Following Immune Checkpoint Inhibitor Therapy in Patients Without Cardiac Adverse Events
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
634-641
DOI: 10.21873/cdp.10479
A Rare Case of Femur Metastasis from Brain Meningioma
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
642-646
DOI: 10.21873/cdp.10480
Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
647-651
DOI: 10.21873/cdp.10481